Skip to content
Menu

ALPS Medical Breakthroughs ETF SBIO

Full chart Compare
Set alert

Price alert · SBIO

All alert types
52.53 USD -0.37 (-0.71%)

Regular-session close

52.53 0.00 0.00%

Pre-market · Nov 20, 4:00 AM ET

52.25 Day range 53.85
45.65 52-week range 70.85
YTD
+2.56%
1 year
+14.00%

5D -4.17 (-7.23%)

545658WedThuFriMonTue53.53
Assets
$180.57M
Expense ratio
0.50%
NAV
53.90
Holdings
103
Top 10 weight
32.7%
Asset class
Equity
Issuer
ALPS Funds
Inception
Dec 30, 2014
YTD return
+2.56%
1-year return
+14.00%
Volume
62.08K
Avg volume
35.54K
Open
53.19
Previous close
52.90
Day's range
52.25 – 53.85
52-week range
45.65 – 70.85
50-day average
38.30
200-day average
35.94

About ALPS Medical Breakthroughs ETF

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on SBIO — it syncs with the Stock Master app.